Intra-Coronary Thrombolysis with Streptokinase or Lys-Plasminogen/Urokinase in Acute Myocardial Infarction: Effects on Recanalization and Blood Fibrinolysis

D de Prost; C Guerot; N Laffay; M H Horellou; M Samama

doi:10.1055/s-0038-1665314

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1983; 50(04): 792-796
DOI: 10.1055/s-0038-1665314

Original Article

Schattauer GmbH Stuttgart

Intra-Coronary Thrombolysis with Streptokinase or Lys-Plasminogen/Urokinase in Acute Myocardial Infarction: Effects on Recanalization and Blood Fibrinolysis

D de Prost

¹The Service d’Hématologie et d’immunologie Biologiques, Université Paris 7, Paris, France

,

C Guerot

²The Service de Cardiologie, C. H. U. Xavier Bichat, Université Paris 7, Paris, France

,

N Laffay

²The Service de Cardiologie, C. H. U. Xavier Bichat, Université Paris 7, Paris, France

,

M H Horellou

³The Laboratoire Central d’Hématologie, C. H. U. Broussais, Hôtel Dieu, Université Paris 6, Paris, France

,

M Samama

³The Laboratoire Central d’Hématologie, C. H. U. Broussais, Hôtel Dieu, Université Paris 6, Paris, France

› Institutsangaben

Abstract

als PDF herunterladen

Summary

Forty-two patients with total occlusion of a coronary vessel were treated with intracoronary fibrinolytic agents. Four therapeutic protocols were compared: group I received streptokinase (SK) as a continuous infusion; group II and III received SK as a bolus at different doses and group IV received lysplasminogen (Pg) plus urokinase (UK); maximal doses were 350,000 IU of SK and 250,000 IU of UK plus 75 μK of Pg. Thrombolysis was assessed by coronary angiography. Coagulation studies were performed prior to, 15 min and 6 hr after the end of the thrombolytic treatment. Recanalization was achieved in 27 of the 31 SK-treated patients (87%) and in 7 of the 11 Pg-UK- treated patients (63.6%). The recanalization frequency was the same in the three SK-treated groups, even though when SK was administered as a bolus, the dose was significantly less than when administered on a continuous infusion. Although systemic fibrinolysis occurred in all 4 groups of patients, this effect was less pronounced in the UK-treated patients than in the three SK- treated groups. This study also shows that recanalization can be achieved with a dose of SK lower than the anti-SK antibody level. Haemorrhagic side effects were minimal in all patients studied. Severe defibrination is usually considered a risk of haemorrhage. These preliminary results suggest that bolus injection of SK or the use of UK plus lys-Pg can reduce the level of defibrination and thus the haemorrhagic risk.

Keywords

Myocardial infarction - Systemic fibrinolysis - Local thrombolysis - streptokinase - Urokinase - Lys-plasminogen

PDF (394 kb)

Referenzen

References
1 Merx W, Dörr R, Rentrop P, Blanke H, Karsch KR, Mathey DG, Kremer P, Rutsch W, Schmutzler H. Evaluation of the effectiveness of intracoronary streptokinase infusion in acute myocardial infarction: postprocedure management and hospital course in 204 patients. Am Heart J 1981; 102: 1181-1187
2 Timmis GC, Gangadharan V, Hauser AM, Ramos RG, Westveer DC, Gordon S. Intracoronary streptokinase in clinical practice. Am Heart J 1982; 104: 925-938
3 Weinstein J. Treatment of myocardial infarction with intracoronary streptokinase: efficacy and safety data from 209 United States cases in the Hoechst-Roussel registry. Am Heart J 1982; 104: 894-898
4 Sharma GV R k, Cella G, Parisi AF, Sasahara AA. Thrombolytic therapy. N Engl J Med 1982; 306: 1268-1276
5 Kötering H, Rentrop P, Kaiser H, Blanke J, Ganasinsky J, Tebbe U, Neuhaus KL. Effect of intracoronary streptokinase-infusion on blood coagulation and fibrinolysis in patients with acute myocardial infarction. Haemostasis 1982; 11 (suppl) (Suppl. 01) 145 (Abstr.)
6 Rentrop P, Blanke H, Karsch KR, Wiegand V, Köstering H, Oster H, Leitz K. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 1979; 2: 354-363
7 Cowley MJ, Hastillo A, Vetrovec GW, Hess ML. Effects of intracoronary streptokinase in acute myocardial infarction. Am Heart J 1981; 102: 1149-1158
8 Fisher LMc A, Garret R, Cowley MJ, Hastillo A, Vetrovec GW. Alterations in blood coagulation associated with low dose intra-coronary infusion of streptokinase in acute myocardial infarction. Haemostasis 1982; 11 (suppl) (Suppl. 01) 80 (Abstr.)
9 Rutsch W, Schartl M, Mathey D, Kuck K, Merx W, Dörr R, Rentrop P, Blanke H. Percutaneous transluminal coronary recanalization: procedure, results and acute complications. Am Heart J 1981; 102: 1178-1181
10 Cowley MJ, Hastillo A, Vetrovec GW, Fisher LM, Garret R, Hess ML. Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency. Circulation 1983; 67: 1031-1038
11 Cernigliaro C, Sansa M, Campi A, Bongo A S, Rossi P. Intracoronary thrombolysis with urokinase in acute myocardial infarction: effects on reperfusion and left ventricular wall motion. In: Fibrinolytic Therapy. Tröbestein G, Etzel F. Schattauer; Stuttgart - New York: 1983. pp 521-526
12 Nobuyoshi M, Nosaka H, Nishimura K. Coronary spasm and throm-bosis in acute myocardial infarction. Circulation 1982; 66 (suppl II) (Suppl. 02) 353 (Abstr.)
13 Tennant S, Campbell WB, Dixon J, Page H, Roach A, Kaiser A. Intracoronary thrombolysis in acute myocardial infarction: compari-son of efficacy of urokinase to streptokinase. Circulation 1982; 66 (suppl II) (Suppl. 02) 1346 (Abstr.)
14 Biggs RM. Human blood coagulation, haemostasis and thrombosis. Blackwell Scientific Publications; Oxford: 1972
15 Von Clauss A. Gerinnungsphysiologische Schnell-Methode zur Be-stimmung des Fibrinogens. Acta Haematol (Basel) 1957; 17: 237-246
16 Milstone H. Factor in normal blood which participates in streptococcal fibrinolysis. J Immunol 1941; 42: 109-116
17 Soria J, Soria C, Samama M. A plasminogen assay using a chromogenic synthetic substrate. Results from clinical work and from studies of thrombolysis. Progress in chemical fibrinolysis and thrombolysis pp 337-346 Raven Press; New York: 1978
18 Juhan I, Calas MF, Buonocore M, Matthieu P, Isnard G, Cazenave B, Serradimigni A. Modifications in coagulation parameters induced by treatment associating urokinase (2000 U CTA/kg/h) with heparin. Thromb Haemostas 1979; 42: 945-954